These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2124222)

  • 21. Effect on growth in pemoline-treated children with attention deficit disorder.
    Friedmann N; Thomas J; Carr R; Elders J; Ringdahl I; Roche A
    Am J Dis Child; 1981 Apr; 135(4):329-32. PubMed ID: 7211792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemoline and lithium in a patient with attention deficit disorder.
    Brown RP; Ingber PS; Tross S
    J Clin Psychiatry; 1983 Apr; 44(4):146-8. PubMed ID: 6403515
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
    Wilens TE; Hammerness PG; Biederman J; Kwon A; Spencer TJ; Clark S; Scott M; Podolski A; Ditterline JW; Morris MC; Moore H
    J Clin Psychiatry; 2005 Feb; 66(2):253-9. PubMed ID: 15705013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression following pemoline withdrawal in a hyperactive child.
    Brown RT; Borden KA; Spunt AL; Medenis R
    Clin Pediatr (Phila); 1985 Mar; 24(3):174. PubMed ID: 3971647
    [No Abstract]   [Full Text] [Related]  

  • 25. Bupropion in children with attention deficit disorder.
    Casat CD; Pleasants DZ; Schroeder DH; Parler DW
    Psychopharmacol Bull; 1989; 25(2):198-201. PubMed ID: 2513592
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse drug reaction. Pemoline and dyskinesia.
    Shuster J
    Nursing; 1999 Feb; 29(2):24. PubMed ID: 10085879
    [No Abstract]   [Full Text] [Related]  

  • 27. Pemoline therapy resulting in liver transplantation.
    Adcock KG; MacElroy DE; Wolford ET; Farrington EA
    Ann Pharmacother; 1998 Apr; 32(4):422-5. PubMed ID: 9562136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemoline (Cylert)-induced hepatotoxicity.
    Elitsur Y
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):143-4. PubMed ID: 2388127
    [No Abstract]   [Full Text] [Related]  

  • 29. [Attention deficit hyperactivity disorder in children].
    Bervoets L
    J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
    [No Abstract]   [Full Text] [Related]  

  • 30. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
    Zametkin AJ; Linnoila M; Karoum F; Sallee R
    Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction.
    Conners CK; Taylor E; Meo G; Kurtz MA; Fournier M
    Psychopharmacologia; 1972; 26(4):321-36. PubMed ID: 4508756
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral pemoline kinetics in hyperactive children.
    Sallee F; Stiller R; Perel J; Bates T
    Clin Pharmacol Ther; 1985 Jun; 37(6):606-9. PubMed ID: 4006361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pemoline in attention deficit disorder and alcoholism: a case study.
    Turnquist K; Frances R; Rosenfeld W; Mobarak A
    Am J Psychiatry; 1983 May; 140(5):622-4. PubMed ID: 6303137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bupropion and compulsive behavior.
    Jacobsen LK; Chappell P; Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):143-4. PubMed ID: 8138514
    [No Abstract]   [Full Text] [Related]  

  • 35. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 36. Substituting stimulants in treating behavior disorders.
    El-Defrawi MH; Greenhill LL
    Am J Psychiatry; 1984 Apr; 141(4):610. PubMed ID: 6703148
    [No Abstract]   [Full Text] [Related]  

  • 37. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.
    Conners CK; Taylor E
    Arch Gen Psychiatry; 1980 Aug; 37(8):922-30. PubMed ID: 7406656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coming into focus. Pharmacologic treatment for ADHD.
    McDonnell MA; Moffett C
    Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychotic side effects of psychostimulants: a 5-year review.
    Cherland E; Fitzpatrick R
    Can J Psychiatry; 1999 Oct; 44(8):811-3. PubMed ID: 10566114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemoline and hepatotoxicity.
    McCurry L; Cronquist S
    Am J Psychiatry; 1997 May; 154(5):713-4. PubMed ID: 9137138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.